Singh A, Collman R G
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
J Virol. 2000 Nov;74(21):10229-35. doi: 10.1128/jvi.74.21.10229-10235.2000.
Human immunodeficiency virus type 1 (HIV-1) variants that use the coreceptor CCR5 for entry (R5; macrophage tropic) predominate in early infection, while variants that use CXCR4 emerge during disease progression. Some late-stage variants use CXCR4 alone (X4; T-cell tropic), while others use both CXCR4 and CCR5 (R5X4; dualtropic). It has been proposed that dualtropic R5X4 strains are intermediates in the evolution from R5 to X4, and we hypothesized that a dualtropic primary-isolate quasispecies might contain variants that represent the spectrum of coreceptor use in vivo. We generated a panel of 35 functional full-length env clones from the primary-isolate quasispecies of a dualtropic prototype strain, HIV-1 89.6(PI). Thirty of the functional env clones (86%) were R5X4, four (11%) were R5, and one (3%) was predominantly X4. V3 to V5 sequences did not reveal clustering by coreceptor usage, and no specific sequence motif or V3 charge pattern corresponded to coreceptor utilization. Complete sequencing of seven functionally divergent Env proteins revealed > or =98.7% homology and conservation of structurally important domains. Chimeras between the R5X4 89.6 prototype and an R5 variant indicated that multiple regions contributed to the use of CXCR4, while chimeras with the X4 variant implicated a single residue in V4 in CCR5 use. These results confirm, at the molecular level, both that dualtropic variants are a predominant component of late-stage syncytium-inducing isolates and that variants restricted to each coreceptor coexist with dualtropic species in vivo. Coreceptor-restricted minority variants may reflect residual R5 species from earlier in disease as well as emerging X4 variants.
1型人类免疫缺陷病毒(HIV-1)利用共受体CCR5进入细胞的变体(R5;嗜巨噬细胞型)在感染早期占主导地位,而利用CXCR4的变体则在疾病进展过程中出现。一些晚期变体仅使用CXCR4(X4;嗜T细胞型),而其他变体则同时使用CXCR4和CCR5(R5X4;双嗜性)。有人提出双嗜性R5X4毒株是从R5向X4进化的中间产物,我们推测双嗜性原代分离株准种可能包含代表体内共受体使用谱的变体。我们从双嗜性原型毒株HIV-1 89.6(PI)的原代分离株准种中生成了一组35个功能性全长env克隆。其中30个功能性env克隆(86%)为R5X4,4个(11%)为R5,1个(3%)主要为X4。V3至V5序列未显示出按共受体使用情况聚类,也没有特定的序列基序或V3电荷模式与共受体利用相对应。对7种功能不同的Env蛋白进行全序列分析,发现其同源性≥98.7%,且结构重要结构域保守。R5X4 89.6原型与R5变体之间的嵌合体表明多个区域对CXCR4的使用有贡献,而与X4变体的嵌合体表明V4中的单个残基与CCR5的使用有关。这些结果在分子水平上证实,双嗜性变体是晚期诱导合胞体分离株的主要成分,并且局限于每个共受体的变体在体内与双嗜性毒株共存。共受体受限的少数变体可能反映疾病早期残留的R5毒株以及新出现的X4变体。